Category Archives: J Invest Dermatol

Epiplakin is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.






Related Articles

Epiplakin is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.

J Invest Dermatol. 2015 Oct 19;

Continue reading

Posted in J Invest Dermatol | Tagged | Leave a comment

Large-Scale Electron Microscopy Maps of Patient Skin and Mucosa Provide Insight into Pathogenesis of Blistering Diseases.






Large-Scale Electron Microscopy Maps of Patient Skin and Mucosa Provide Insight into Pathogenesis of Blistering Diseases.
J Invest Dermatol. 2015 Mar 19;
Authors: Sokol E, Kramer D, Diercks GF, Kuipers J, Jonkman MF,… Continue reading






Posted in J Invest Dermatol | Leave a comment

Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.






Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.
J Invest Dermatol. 2015 Feb 17;
Authors: Vorobyev A, Ujiie H, Recke A, Buijsrogge JJ, Jonkman MF, Pas HH, Iwat… Continue reading






Posted in J Invest Dermatol | Leave a comment

Transgenic mouse technology in skin biology: generation of knockin mice.






Transgenic mouse technology in skin biology: generation of knockin mice.

J Invest Dermatol. 2014 Dec;134(12):e27

Authors: Tellkamp F, Benhadou F, Bremer J, Gnarra M, Knüver J, Schaffenrath S, Vorhagen S

PMID: 25381772 [PubMed – in process]

Continue reading






Posted in J Invest Dermatol | Leave a comment

No evidence of apoptotic cells in pemphigus acantholysis.






Related Articles

No evidence of apoptotic cells in pemphigus acantholysis.

J Invest Dermatol. 2014 Jul;134(7):2039-41

Authors: Janse IC, van der Wier G, Jonkman…

Continue reading






Posted in J Invest Dermatol | Tagged | Leave a comment

From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.






Related Articles
From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.
J Invest Dermatol. 2014 Sep;134(9):2298-300
Authors: Ludwig RJ, Borradori L, Diaz … Continue reading






Posted in J Invest Dermatol | Tagged , | Leave a comment

Targeting PKC in human T cells using sotrastaurin (AEB071) preserves regulatory T cells and prevents IL-17 production.






Related Articles

Targeting PKC in human T cells using sotrastaurin (AEB071) preserves regulatory T cells and prevents IL-17 production.

J Invest Dermatol. 2014…

Continue reading






Posted in J Invest Dermatol | Tagged | Leave a comment

Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy.






Related Articles

Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy.

J Invest Dermatol. 2014 Feb;134(2):571-4

Authors: …

Continue reading






Posted in J Invest Dermatol | Tagged | Leave a comment

Smaller Desmosomes are Seen in the Skin of Pemphigus Patients with Anti-Desmoglein 1 Antibodies but not in Patients with Anti-Desmoglein 3 Antibodies.






Smaller Desmosomes are Seen in the Skin of Pemphigus Patients with Anti-Desmoglein 1 Antibodies but not in Patients with Anti-Desmoglein 3 Antibodies.

J Invest Dermatol. 2014 Mar 12;

Continue reading






Posted in J Invest Dermatol | Tagged | Leave a comment

Plectin mutations underlie epidermolysis bullosa simplex in 8% of patients.






Related Articles
Plectin mutations underlie epidermolysis bullosa simplex in 8% of patients.
J Invest Dermatol. 2014 Jan;134(1):273-6
Authors: Bolling MC, Jongbloed JD, Boven LG, Diercks GF, Smith FJ, McLean WH, Jonkman MF
Continue reading






Posted in J Invest Dermatol | Tagged , | Leave a comment

Mechanisms of Natural Gene Therapy in Dystrophic Epidermolysis Bullosa.






Related Articles

Mechanisms of Natural Gene Therapy in Dystrophic Epidermolysis Bullosa.

J Invest Dermatol. 2014 Feb 27;

Authors: Kiritsi D, Garcia M, Brander R, Has C,…

Continue reading






Posted in J Invest Dermatol | Tagged | Leave a comment

High Anti-Staphylococcal Antibody Titers in Patients with Epidermolysis Bullosa Relate to Long-Term Colonization with Alternating Types of Staphylococcus aureus.






High Anti-Staphylococcal Antibody Titers in Patients with Epidermolysis Bullosa Relate to Long-Term Colonization with Alternating Types of Staphylococcus aureus.

J Invest Dermatol. 2012 Sep…

Continue reading






Posted in J Invest Dermatol | Tagged , | Leave a comment

Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.






Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.

J Invest Dermatol. 2012 May;132(5):1374-83

Continue reading






Posted in J Invest Dermatol | Tagged , | Leave a comment

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells.






The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells.
J Invest Dermatol. 2012 May 10;
Authors: Wiersma VR, de Bruyn M, van Ginkel RJ, Sigar E, Hirashima M, Niki T, Nishi N, Samplonius DF, H… Continue reading






Posted in J Invest Dermatol | Tagged , | Leave a comment

Realm of revertant mosaicism expanding.






Realm of revertant mosaicism expanding.

J Invest Dermatol. 2012 Mar;132(3):514-6

Authors: Jonkman MF, Pasmooij AM

Abstract

In this issue, Lai-Cheong et al. report…

Continue reading






Posted in J Invest Dermatol | Tagged , | Leave a comment

Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation.






Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation.
J Invest Dermatol. 2011 Jan;131(1):59-66
Authors: Isard O, Knol AC, Ariès MF, Nguyen JM, Khammari A, Castex-Ri… Continue reading






Posted in J Invest Dermatol | Tagged , | Comments Off on Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation.

Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.






Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.
J Invest Dermatol. 2010 Oct;130(10):2407-11
Authors: Pasmooij AM, Garcia M, Escamez MJ, Nijenhuis AM, … Continue reading






Posted in J Invest Dermatol | Tagged , | Comments Off on Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.

Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa.






Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa.
J Invest Dermatol. 2010 Nov;130(11):2680-3
Authors: Hobbs RP, Han SY, van der Zwaag PA, Bolling MC, Jongbloed JD, Jonkman MF, Get… Continue reading






Posted in J Invest Dermatol | Tagged , | Comments Off on Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa.

Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells.






Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells.
J Invest Dermatol. 2011 Jul;131(7):1412-9
Authors: D’Alessandro M, Coats SE, Jonkman MF, Jonkmann MF, Leigh IM, Lane EB
Continue reading






Posted in J Invest Dermatol | Tagged , | Comments Off on Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells.